✦ LIBER ✦

Neuropeptide Y receptors as therapeutic targets in anxiety and depression

✍ Scribed by Tammy J. Sajdyk

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 123 KB
Volume: 65
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.20031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Histamine receptors as potential therape

Histamine receptors as potential therapeutic targets to treat anxiety and depression

✍ Jacob Raber 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Galanin receptors as novel drug targets

Galanin receptors as novel drug targets for the treatment of depression and anxiety

✍ Xiaoying Lu; Alasdair M. Barr; Tamas Bartfai 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Differential roles for neuropeptide Y Y1

Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation

✍ Gunnar Sørensen; Camilla Lindberg; Gitta Wörtwein; Tom G. Bolwig; David P.D. Wol 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB

## Abstract Central administration of neuropeptide Y (NPY) causes both anxiolysis and sedation. Previous studies suggest that both effects are mediated via NPY Y1 receptors. However, most of these studies were carried out before the advent of specific NPY receptor ligands. Therefore, a potential ro

Retinoid receptors, transporters, and me

Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease

✍ Ann B. Goodman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 1 views

## Abstract Vitamin A (retinoid) is required in the adult brain to enable cognition, learning, and memory. While brain levels of retinoid diminish over the course of normal ageing, retinoid deficit is greater in late onset Alzheimer disease (LOAD) brains than in normal‐aged controls. This paper rev

Platelet-derived growth factor receptor

Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

✍ Tadahiko Kubo; Sajida Piperdi; Jeremy Rosenblum; Cristina R. Antonescu; Wen Chen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB 👁 2 views

## Abstract The purpose of this review was to determine whether imatinib mesylate (STI571, Gleevec) has a role in the treatment of osteosarcoma. The expression of platelet‐derived growth factor (PDGF) receptor and its ligand was examined in a panel of surgical specimens obtained from 54 osteosarcom

Angiotensin II type 1 receptor as a nove

Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis

✍ A. Price; J. C. Lockhart; W. R. Ferrell; W. Gsell; S. McLean; R. D. Sturrock 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract ## Objective Angiotensin II (Ang II) is known to have proinflammatory actions, and Ang II type 1 (AT~1~) receptors are up‐regulated in the rheumatoid synovium, suggesting that this receptor could be a therapeutic target. The purpose of this study was to investigate the antiinflammatory